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SUMMARY
Animal studies have shown that acetylcholine de-
creases excitatory receptive field size and spread
of excitation in early visual cortex. These effects are
thought to be due to facilitation of thalamocortical
synaptic transmission and/or suppression of intra-
cortical connections. We have used functional mag-
netic resonance imaging (fMRI) to measure the spa-
tial spread of responses to visual stimulation in
human early visual cortex. The cholinesterase inhib-
itor donepezil was administered to normal healthy
human subjects to increase synaptic levels of acetyl-
choline in the brain. Cholinergic enhancement with
donepezil decreased the spatial spread of excitatory
fMRI responses in visual cortex, consistent with
a role of acetylcholine in reducing excitatory recep-
tive field size of cortical neurons. Donepezil also re-
duced response amplitude in visual cortex, but the
cholinergic effects on spatial spread were not a direct
result of reduced amplitude. These findings demon-
strate that acetylcholine regulates spatial integration
in human visual cortex.
INTRODUCTION
The neurotransmitter acetylcholine (ACh) has been implicated in
a variety of cognitive processes, including learning and memory
(Hasselmo, 2006) and attention (Sarter et al., 2005). The physio-
logical effects of ACh in the brain have typically been investi-
gated in animal experiments, while behavioral effects have
been extensively characterized by administering cholinergic
drugs to human subjects. However, little is known regarding
the physiological effects of ACh in the human brain. We manip-
ulated synaptic ACh levels by administering the Alzheimer’s dis-
ease medication and cholinesterase inhibitor donepezil (trade
name: Aricept) to healthy human subjects. Donepezil enhances
cholinergic synaptic transmission in the brain by inhibiting the
enzyme that metabolizes ACh in the synaptic cleft, thereby pro-
longing the effective lifetime of this neurotransmitter. The effects
of cholinergic enhancement on responses to visual stimuli in vi-
sual cortex were assessed using functional magnetic resonance
imaging (fMRI).
A number of experiments have provided evidence that, in ce-
rebral cortex, ACh increases thalamocortical synaptic transmis-
sion relative to lateral intracortical connections (reviewed in Gio-
como and Hasselmo, 2007). Other studies have demonstrated
a role for ACh in the regulation of spatial integration of activity
within visual cortex. ACh reduced spread of excitatory activity
following electrical stimulation of rat visual cortical slices (Kimura
et al., 1999) and decreased the preferred length of visual stimuli
in marmoset V1 neurons (Roberts et al., 2005).
A shift in the balance of cortical inputs by ACh in favor of tha-
lamocortical relative to intracortical inputs would be expected to
decrease excitatory receptive field (RF) size, as the size of the
classical RF, or minimum response field, is thought to be largely
determined by thalamocortical inputs, while the excitatory por-
tion of the surrounding extraclassical RF is due mainly to intra-
cortical connections (Angelucci and Bressloff, 2006). Based on
the animal physiology studies, ACh would suppress the intra-
cortical inputs that give rise to the extraclassical RF relative to
the feedforward thalamocortical inputs that are responsible for
the classical RF. This would result in a reduction in overall excit-
atory RF size. We hypothesized that if enhancing cholinergic
transmission with donepezil decreased excitatory RF size of
a large population of visual cortical neurons in the human brain,
this would reduce the spatial spread of excitatory visual re-
sponses within visual cortex. In this context, a reduced spatial
spread of visual responses can be seen as a shift in the respon-
siveness of cortex toward feedforward inputs and away from lo-
cal intrinsic processing.
We employed a combination of retinotopic mapping of
early visual cortical areas, representation of the spatial spread
of visual responses on computationally flattened patched of
visual cortex, and a novel analysis method to quantify spatial
spread of excitatory visual responses within the cortical gray
matter. In agreement with the hypothesis outlined above, we
found that increasing cholinergic transmission with donepezil
reduced spatial spread of excitatory visual responses in human
early visual cortex.
RESULTS
Functional MRI (fMRI) was used to measure the spatial spread of
visual responses in early visual cortex and modulation of
this spatial spread by cholinergic enhancement. Subjects pas-
sively viewed a high-contrast, contrast-reversing checkerboard904 Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc.
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Cholinergic Enhancement Reduces Spatial Spreadannulus in block alternation with a blank gray screen while main-
taining fixation on a central point. A sinusoid with a period equal
to that of the block alternation (19.2 s) was fit to the fMRI time se-
ries of each voxel in retinotopically mapped visual cortical areas
V1, V2, and V3. The free parameters of the sinusoidal fit were am-
plitude (corresponding to the magnitude of the visually driven re-
sponse) and phase (corresponding to the temporal delay of the
response relative to the stimulus block alternation). Amplitude
and phase values were displayed on computationally flattened
patches of visual cortex.
The spatial distribution of response phases on the cortical sur-
face was consistent with the known retinotopic organization of
early visual cortical areas. Positive BOLD responses to the
checkerboard stimulus relative to the gray screen were observed
in V1, V2, and V3 at visual field locations corresponding to the ec-
centricities of the stimulus annulus (Figure 1A). Negative BOLD
responses (stimulus caused a decrease in response relative to
the gray screen) were observed both peripheral and central to
the positive BOLD region (Figure 1A). These negative BOLD re-
sponses extended into the foveal confluence and peripherally
for a few centimeters beyond the retinotopic representation of
the outer boundary of the stimulus annulus.
The response phase values for all the pixels in each hemi-
sphere of each visual area were displayed as a histogram (Fig-
ure 1B). This histogram was bimodal, with one mode corre-
sponding to the positive BOLD response to the stimulus and
the other mode containing pixels with negative BOLD responses
(Figure 1B). The histograms were fit with two Gaussians, one for
each mode. The crossing points of the two Gaussians were used
to define the phase boundaries that distinguished positive BOLD
from negative BOLD responses. The spatial spread of the excit-
atory visual response was defined as the fraction of pixels within
the positive BOLD region of the phase histogram.
The hemodynamic response function (HRF) describes the re-
lationship between neural activity and the BOLD response. Spe-
cifically, the BOLD response is delayed and temporally low-pass
filtered relative to the time course of neural activity. If the first
peak of the pixel histogram shown in Figure 1B represents an ex-
citatory response to visual stimulation, then the average fMRI
time course from pixels in this phase window should closely
match a convolution of the expected neural activity time series
and the HRF. This is exactly the result that was obtained
(Figure 2A). Similarly, pixels comprising the second peak of the
phase histogram exhibited a BOLD time course consistent with
a decrease in neural activity during stimulus presentation
(Figure 2B).
The cholinesterase inhibitor and Alzheimer’s disease medica-
tion donepezil (trade name: Aricept) was administered to in-
crease synaptic levels of ACh. Donepezil reduced the spatial
spread of the excitatory visual response. That is, the positive
BOLD response to the stimulus occupied less of the cortical sur-
face following cholinergic enhancement with donepezil (Figure 3).
Mean pixel phase histograms and binarized cortical flat maps for
individual subjects are presented as Supplemental Data. The
histograms all exhibit a bimodal distribution of response phases
corresponding to positive and negative BOLD responses to the
visual stimulus (Figure S1). Additionally, the binarized flat maps
show that the spatial distributions of the pixels with positive
BOLD responses correspond to the retinotopic representation
of the stimulus in early visual cortex, while more peripheral visual
field representations contain pixels with negative BOLD re-
sponses (Figure S2). Figure 2C displays the average responses
for pixels that were classified as having a positive BOLD re-
sponse under placebo and a negative BOLD response under do-
nepezil. These two sinusoidal time courses are 180 out of phase
with respect to each other, demonstrating that the pixel classifi-
cation procedure used to measure spatial spread identifies
a population of visual cortical pixels that change their response
to visual stimulation from positive to negative following choliner-
gic enhancement with donepezil.
For the group of five subjects, the effects of cholinergic en-
hancement on spatial spread were significant in areas V1 and
Figure 1. Responses to Visual Stimulation Have a
Bimodal Phase Distribution in Early Visual Cortex
A checkerboard annulus stimulus was presented in block al-
ternation with a gray screen. A sinusoid with a frequency equal
to the frequency of block alternation (0.0521 Hz) was fit to the
fMRI time course of each pixel in a computationally flattened
patch of early visual cortex. The phase of this sinusoid relative
to the stimulus cycle was color coded according to the color
map above panel (B) and plotted on the flat map of the right
hemisphere of subject #4. No spatial smoothing or statistical
thresholding was performed.
(A) Spatial distribution of response phases in cortical areas V1,
V2, and V3. The shape of half of the stimulus annulus can be
seen in the pattern of responses in early visual cortex. Due
to the contralateral organization of the visual pathways, the
left side of the stimulus annulus is represented in this right
hemisphere flat map. At the foveal confluence and in regions representing peripheral visual field locations, the phases are mainly blue, consistent with a negative
BOLD (inhibitory) response to the stimulus. In between, the phases are mainly yellow and orange, consistent with a positive BOLD response. Average data are
shown here to demonstrate the spatial distribution of positive and negative BOLD responses, but all the quantitative analysis of donepezil effects was performed
on single 5 min fMRI runs without averaging. The borders between the positive and negative BOLD responses are indicated by white lines and correspond to the
inner and outer boundaries of half of the stimulus annulus.
(B) Pixel histogram of the data shown in panel (A). The distribution of response phases was bimodal, with one mode corresponding to positive BOLD responses
and the other corresponding to negative BOLD responses. This phase distribution was well fit by the two-Gaussian model.Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc. 905
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Cholinergic Enhancement Reduces Spatial SpreadV3 but not V2 (Figure 4). In areas V1 and V3, the reduction in spa-
tial spread relative to placebo was 8.5% and 7.3%, respectively,
corresponding to a decrease in visual space of 0.4 of visual
angle. Inspection of individual flat maps revealed that a single
donepezil fMRI session of subject #5 was unlike all the other ses-
sions in that donepezil caused a substantial (15%) increase in ex-
citatory spatial spread that was limited to a single cortical area
(V2). We do not currently have an explanation for this finding,
but the fact that this single session produced unusual results in
V2 but not in neighboring cortical areas V1 and V3 suggests
that this session may have been contaminated by an imaging ar-
tifact. If this aberrant session is excluded (representing 4 out of
a total of 84 fMRI runs), the effects of donepezil on excitatory
spatial spread are much more consistent across the three visual
areas. The consequences of excluding this session on subject
#50s mean pixel histograms (Figure S1), subject #50s binarized
flat maps (Figure S2), and on the spatial spread bar graphs for
subject #5 and the entire group of five subjects (Figure S3) are
included as Supplemental Data. Analysis of the spatial spread
results following exclusion of the aberrant session indicated
a statistically significant reduction in spatial spread following do-
nepezil administration in all three visual cortical areas. Choliner-
gic enhancement also reduced the amplitude of the visually
evoked positive BOLD response in areas V1, V2, and V3 (Figure 4)
and increased the amplitude of the negative BOLD response in
V1 (Figure S4).
In conventional statistical parametric mapping analyses of
BOLD responses, spatial spread and response amplitude are
usually confounded. Typically, a statistical threshold is chosen,
and voxels with t statistic values that exceed the threshold are
displayed and analyzed. Any manipulation that reduces re-
sponse amplitude will also reduce the signal-to-noise ratio of
the response. This will result in fewer suprathreshold voxels
and an apparent decrease in the spatial extent of the activated
region (Saad et al., 2003). In contrast, the analysis we employed
assigns a phase to every pixel in the flat map, regardless of the
amplitude or reliability of the response. Each pixel is included
Figure 2. Correlation of fMRI Time Courses with Models Based
on Expected Time Courses of Neural Activity
(A) Step function at the bottom indicates the timing of stimulus presentation
and the expected time course of activity for neurons excited by the stimulus.
Black line, convolution of this step function with a canonical hemodynamic re-
sponse function (HRF). Red line, actual mean fMRI time series from pixels in
the positive BOLD phase window in the histogram shown in Figure 1B. The
actual and modeled time courses are very similar.
(B) Step function shows expected response for neurons that are inhibited by
stimulus presentation. Black line, convolution of this step function with the
HRF. Blue line, mean fMRI time series from pixels in the negative BOLD phase
window in the histogram in Figure 1B. Again, the two curves are similar. In ad-
dition, they are both 180 out of phase relative to the positive BOLD responses
shown in panel (A).
(C) Step function as in panel (A). Black line, convolution of step function with
the HRF. The purple and green lines are average fMRI time series from the pop-
ulation of pixels that were classified as having a positive BOLD response under
placebo (red in left panel of Figure 3) and a negative BOLD response under
donepezil (blue in right panel of Figure 3). This demonstrates that the same
population of pixels can respond either positively (purple) or negatively (green),
depending on the level of cholinergic enhancement.
Figure 3. The Spatial Spread of the Positive BOLD Response to
Visual Stimulation Is Reduced following Donepezil Administration
Each cortical flat-map pixel in the left hemisphere of subject #4 was assigned
a color based on the phase of its response relative to the stimulus cycle. Red,
pixels with a positive BOLD (excitatory) response to the checkerboard stimu-
lus. Blue, pixels with a negative BOLD (inhibitory) response. Yellow, boundary
between the positive BOLD region and the surrounding negative BOLD region,
drawn based on the placebo condition. Donepezil reduced the number of
pixels with a positive BOLD response and increased the number of pixels
with a negative BOLD response to the stimulus.906 Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc.
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Gaussian fit, thereby avoiding the ‘‘iceberg’’ problem created
by statistical thresholding. Nevertheless, we directly tested
whether the reduction in spatial spread caused by donepezil
could artifactually result from the effects of cholinergic enhance-
ment on response amplitude. For each 5 min run, we correlated
the change in magnitude of the positive BOLD response follow-
ing donpezil administration with the drug-induced change in
positive BOLD spatial spread. These measures were not signifi-
cantly correlated in any of the three visual areas (Figure 5).
Because the subjects differed in both mean and variance of
the effects of donepezil on spatial spread and amplitude of pos-
itive BOLD responses (Figure 4), pooling all the data across sub-
jects could have obscured a possible correlation between these
two measures. To test this directly, we computed z scores for the
percent change in spatial spread and positive amplitude values
relative to placebo and correlated these two sets of standardized
z scores. They were not significantly correlated in any area (cor-
relation coefficients: 0.07 in V1, 0.11 in V2, and 0.11 in V3).
Therefore, even though donepezil generally reduced both spatial
spread and amplitude of positive BOLD visual cortical re-
sponses, the decrease in spatial spread was not directly due
to a reduction in response amplitude.
The BOLD signal measured with fMRI can be modulated by al-
terations in neural activity as well as changes in neurovascular
coupling or the vasculature itself. Breath holding elevates
BOLD signals in the cortex (Stillman et al., 1995) by causing hy-
percapnia that results in vascular dilation and increased blood
flow (Li et al., 1999). We tested whether donepezil had any effect
on the breath holding BOLD response. Subjects alternated
blocks of breath holding with paced breathing. This generated si-
nusoidal modulation of BOLD signal over the entire cerebral cor-
tex. The mean amplitudes and response phases of the sinusoidal
fits for each gray matter voxel were computed for areas V1, V2,
and V3. Donepezil produced no significant differences in ampli-
tude, but it reduced the response phase (temporal delay) of the
breath holding response in areas V1 and V3 (Figure 6). These
changes in the temporal properties of the BOLD response would
not be expected to have important consequences for the mea-
surement of spatial spread of visual responses. A decrease in
response delay would shift the phase values in the pixel histo-
grams toward lower values (Figure 1B), but presumably the
bimodal distribution and the assignment of each pixel to
either the positive or negative BOLD mode would be largely
unaffected.
We also measured the effects of donepezil on the other free
parameters of the two-Gaussian fit of the visually evoked re-
sponse phase pixel histogram. These included means of the
Gaussians (corresponding to the temporal delays of the positive
and negative BOLD responses relative to the stimulus cycle), the
standard deviations of the Gaussians (corresponding to the
widths of the peaks in the pixel histogram), and a y-offset term
(modeled as a constant value that was added to all bins of the
pixel histogram). In general, cholinergic enhancement had fairly
minimal effects on these measures, although there was a consis-
tent increase in the value of the y-offset term in all three visual
Figure 4. Donepezil Reduced Spatial
Spread and Amplitude of Excitatory Visual
Responses in Early Visual Cortex
For each 5 min fMRI run, a phase histogram like
that shown in Figure 1B was generated and fit
with the two-Gaussian model. This allowed the
categorization of each pixel as either positive or
negative BOLD. The fraction of positive BOLD re-
sponses was computed separately for left and
right hemispheres in each visual area. In addition,
the amplitude of the best-fit sinusoid was com-
puted for each pixel that was classified as having
a positive BOLD response to the stimulus. Error
bars are SEM. *p < 0.05; **p < 0.001.
Figure 5. The Effects of Donepezil on Spa-
tial Spread and on the Amplitude of Excit-
atory Visual Responses Were Uncorrelated
For each fMRI run in the donepezil sessions, the
proportion of positive BOLD pixels (spatial spread)
and the response amplitude of these positive
BOLD pixels were measured and normalized by
the corresponding mean values in the placebo
condition.Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc. 907
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Cholinergic Enhancement Reduces Spatial Spreadareas following donepezil administration (Figures S5–S7). In ad-
dition, there was no effect of donepezil on the mean squared er-
ror, an estimate of the goodness-of-fit of the two-Gaussian
model (Figure S8).
Finally, we measured the effects of cholinergic enhancement
on visual fixation stability. In principle, changes in fixation stabil-
ity following donepezil administration could result in artifactual
alterations of spatial spread. Deviations from fixation would
cause the visual stimulus to activate a larger portion of the retina
over an entire fMRI run. While the precise consequences of this
for spatial spread measurements would depend on the temporal
properties of the eye movements, it is nevertheless a potential
confound. We measured the effects of donepezil on fixation
stability for four of the five subjects who participated in the
fMRI experiments. Eye position was measured in a behavioral
testing room outside the scanner. The pharmacological proce-
dures and checkerboard annulus stimulus were identical to
those used in the fMRI experiments.
The most direct measure of fixation stability is the standard
deviation of eye position. This was measured for both horizontal
and vertical eye position (Table 1). We also computed the per-
centage of time that subjects successfully maintained eye posi-
tion within a 1 radius circular window centered at fixation. In
general, the subjects maintained fixation very effectively. The
standard deviations of the eye position traces were small (aver-
aging less than 0.5 of visual angle), and the eye position was
within 1 of the fixation point for a substantial portion of time (av-
eraging more than 85%). Most importantly for this study, there
was no consistent effect of cholinergic enhancement with done-
pezil on fixation stability. Subjects #2 and #3 had more stable fix-
ation for placebo than for donepezil, while subjects #4 and #5
showed the opposite effect. These results provide strong evi-
dence against a role for eye movements in the observed effects
of donepezil on excitatory spatial spread in visual cortex.
Cholinergic synapses in the eye regulate pupil size, and
chronic daily administration of 5 mg donepezil to patients with
Alzheimer’s disease reduced pupil size by 7% (Estermann
et al., 2006). If acute administration of donepezil decreased pupil
size in our study, this would have reduced the overall amount of
light reaching the retina. However, luminance adaptation renders
many neurons in the visual system fairly insensitive to small
and slow changes in overall light levels. Therefore, it is unlikely
that the effects of donepezil on excitatory spatial spread of
responses in visual cortex are due to changes in pupil size.
DISCUSSION
Relation to Previous Studies
We have shown that increasing synaptic ACh levels reduces the
spatial spread of excitatory visual responses in human early vi-
sual cortex. Measurement of spatial spread of responses with
fMRI reflects the activity of large populations of visual cortical
neurons. The most direct analog of this measure in single-unit
electrophysiology studies is the excitatory receptive field (RF)
size of visual cortical neurons. Indeed, local iontophoresis of
Figure 6. Effects of Donepezil on the BOLD Response to Breath Holding
Subjects alternated blocks of breath holding and paced breathing, and a sinusoid with a period equal to the period of block alternation (48 s) was fit to the fMRI
time series for each visual cortical flat-map pixel. The mean response amplitude (blue) and phase (red, corresponding to the temporal delay of the BOLD re-
sponse) are shown. For the group of five subjects, donepezil had no effect on mean amplitude and decreased mean phase relative to placebo in areas V1
and V3. Error bars are SEM. *p < 0.05.
Table 1. Donepezil Had Minimal Effect on Fixation Stability
during Passive Viewing of the Checkerboard Stimulus Annulus
Placebo Donepezil
Subject
#
SDx
(deg)
SDy
(deg)
% Fix
Wind.
SDx
(deg)
SDy
(deg)
% Fix
Wind.
2 0.34 0.29 78 0.59 0.89 56
3 0.26 0.32 98 0.34 0.39 89
4 0.38 0.35 94 0.34 0.27 97
5 0.66 0.56 91 0.63 0.42 93
Group 0.41 0.38 90 0.47 0.49 84
Subjects #2 to #5 from the fMRI portion of this study repeated the passive
viewing experiment in a behavioral testing room. The pharmacological
procedures and visual stimulus were identical to those used in the fMRI
experiments. Time series of horizontal (x) and vertical (y) position were re-
corded, and the standard deviation (SDx and SDy) over each 5 min run
was computed. Standard deviations are presented in units of degrees
of visual angle. In addition, a circular fixation window of 1 radius was de-
fined, and the percent of viewing time during which the eye position was
within this window was measured. None of the three eye position mea-
sures showed significant differences between placebo and donepezil
sessions (paired t test).908 Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc.
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stimuli in marmoset V1 neurons (Roberts et al., 2005). Addition-
ally, in slices of rat visual cortex, bath application of ACh reduced
the spread of excitation following electrical stimulation at the
white matter/layer VI border, as measured with voltage-sensitive
optical imaging (Kimura et al., 1999).
The size and spatial organization of V1 RFs result from a com-
bination of feedforward inputs from the lateral geniculate nucleus
(LGN), lateral connections from other V1 neurons, and feedback
projections from extrastriate areas (reviewed in Angelucci and
Bressloff, 2006). The classical receptive field (CRF), or minimum
response field, for a given neuron corresponds to the visual field
locations where presentation of small optimal stimuli evokes an
excitatory response in that neuron. The spatial extent of the
CRF of a given V1 neuron closely matches the visuotopic extent
of the LGN neurons that project to that cell (Angelucci and Sains-
bury, 2006). For many visual cortical neurons, increasing the size
of the visual stimulus reveals the presence of an additional excit-
atory component of the RF that surrounds the CRF, known as the
summation receptive field, or SRF. Further increases in stimulus
size beyond the SRF often result in a decrease in the magnitude
of visual responses, or surround suppression (Hubel and Wiesel,
1965; DeAngelis et al., 1994; Sceniak et al., 1999; Cavanaugh
et al., 2002). The spatial extent of the SRF of a given V1 cell is
very similar to the visuotopic extent of the V1 neurons that pro-
ject to that cell through lateral connections (Angelucci et al.,
2002). Taken together, these results suggest that the center of
a V1 receptive field (the CRF) corresponds mainly to feedforward
inputs from the LGN, while the surrounding portions of the excit-
atory receptive field (the SRF) are associated primarily with lat-
eral intracortical connections.
One possible mechanism to account for the reduction in spa-
tial spread in visual cortex by ACh is a shift in the balance of feed-
forward and lateral synaptic transmission. In general, pharmaco-
logical enhancement of cholinergic activity boosts afferent
inputs relative to intracortical connections. This was first shown
in rat piriform cortex, which exhibits a laminar segregation of
afferent inputs and excitatory intrinsic fibers (Hasselmo and
Bower, 1992). In neocortex, electophysiological recordings
have shown that ACh enhances thalamocortical relative to intra-
cortical transmission in brain slices (Gil et al., 1997; Hsieh et al.,
2000) and in vivo (Disney et al., 2007; Metherate and Ashe, 1993;
Oldford and Castro-Alamancos, 2003). The results of Kimura
et al. (1999) are also consistent with this, as ACh caused less
suppression of excitatory spatial spread in the thalamocortical-
recipient layer IV compared to superficial or deep cortical layers.
A shift in the balance of cortical inputs by ACh in favor of tha-
lamocortical relative to intracortical inputs in human visual cortex
would be expected to enhance the CRF relative to the SRF, re-
sulting in a decrease in excitatory RF size. At the population level,
reduction of excitatory receptive field size over many neurons
should reduce excitatory spatial spread, as we have observed
with fMRI.
Simultaneous electrophysiological and fMRI recordings in ma-
caque visual cortex have demonstrated that local field potential
(LFP) signals more effectively predict the BOLD response than
multiunit spiking activity (MUA) (Logothetis et al., 2001). To the
extent that fMRI signals should be considered to represent syn-
aptic inputs and subthreshold processing rather than spiking
activity in a given area, this would call into question our interpre-
tation of the fMRI spatial spread results in terms of receptive
fields of individual visual cortical neurons. However, both LFP
and MUA signals are highly correlated with the BOLD signal,
and the differences between their correlations with the BOLD
signal are small (Logothetis et al., 2001). Additionally, LFP and
MUA responses to visual stimulation have been reported to be
equally well-correlated with BOLD responses in cat visual cor-
tex, providing that activity is integrated over at least several mil-
limeters of cortex (Kim et al., 2004). Our spatial spread measures
typically include hundreds of square millimeters of cortex in
a given visual area.
Finally, recordings of MUA, LFP, and BOLD responses to vi-
sual stimulation in macaque V1 demonstrated that the electro-
physiological signals increased in regions exhibiting a positive
BOLD response and decreased in regions with a negative
BOLD response (Shmuel et al., 2006). Also, the MUA and LFP
signals were equally well correlated with the negative BOLD re-
sponse in this study. Thus, the available evidence, at least in
early visual cortex, supports a strong relationship between spik-
ing activity in visual cortical neurons and fMRI responses in these
areas.
Possible Sites of Action of Cholinergic Enhancement
Donepezil and other cholinesterase inhibitors prolong the life-
time of ACh in the synaptic cleft by blocking the enzyme that me-
tabolizes ACh. Manipulation of the cholinergic system with cho-
linesterase inhibitors is more physiologically relevant than using
ACh receptor agonists or antagonists. Receptor agonists and
antagonists interact directly with particular receptor subtypes
and alter cholinergic activity at all synapses where those recep-
tor subtypes are located, independent of the endogenous activ-
ity at those synapses during the response to the stimulus or
performance of the relevant task. In contrast, cholinesterase in-
hibition enhances cholinergic activity only at synapses where
ACh is currently being endogenously released. It therefore am-
plifies the effects of ACh at those cholinergic synapses that are
active during the experimental manipulation of interest.
A disadvantage of cholinesterase inhibitors is that they do not
provide information regarding the ACh receptor subtypes that
might be mediating their effects. In the present study, donepezil
could be acting on any of the following ACh receptor popula-
tions: presynaptic nicotinic receptors on thalamocortical affer-
ents in layer IV (Prusky et al., 1987; Disney et al., 2007), musca-
rinic receptors on cortical neurons (Levey et al., 1991), or
nicotinic receptors on thalamocortical axons (located on the por-
tion of the axon proximal to the presynaptic terminals) (Kawai
et al., 2007).
In addition, cholinergic enhancement could be affecting top-
down inputs to early visual cortex. Basal forebrain cholinergic
axons project to the hippocampus and the entire cerebral cortex
(Mesulam, 2004). A number of studies have demonstrated
changes in fMRI activity in human brain areas outside of visual
cortex following administration of cholinergic drugs. The musca-
rinic receptor antagonist scopolamine reduced the extent and
magnitude of encoding-related fMRI responses in the hippo-
campus, fusiform gyrus, and inferior prefrontal cortex (SperlingNeuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc. 909
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with long-term encoding in parahippocampal and hippocampal
regions (Schon et al., 2005). Additionally, the cholinesterase in-
hibitor physostigmine has been shown to modulate top-down vi-
sual working memory (Furey et al., 2000) and visual spatial atten-
tion signals (Bentley et al., 2004; Bentley et al., 2008) There are
many examples of cholinergic regulation of visual attention in
both humans and animal models (Hasselmo and McGaughy,
2004; Sarter et al., 2005). Future studies that directly compare at-
tentional and pharmacological modulation of visual responses
will clarify the possible role of top-down attention on excitatory
spatial spread. Interestingly, top-down attention has been re-
ported to have similar effects to ACh on spatial integration of in-
dividual macaque V1 neurons. Specifically, allocation of spatial
attention to a visual field location within the recorded neuron’s
receptive field reduced receptive field size at parafoveal (but
not peripheral) eccentricities (Roberts et al., 2007).
Cholinergic Effects on Response Amplitude
In the present study, donepezil reduced the amplitude of excit-
atory visual responses in visual cortex. Jacobsen et al. (2002)
reported no effect of intravenous nicotine administration on visu-
ally-evoked BOLD responses in occipital cortex, and the musca-
rinic receptor antagonist scopolamine did not alter either the
response magnitude or spatial extent of visual cortical fMRI
responses (Sperling et al., 2002). In addition, the cholinesterase
inhibitor physostigmine did not affect regional cerebral blood
flow (rCBF) responses to visual stimulation in Brodmann’s area
17 (calcarine cortex) as measured with positron emission tomog-
raphy, but it did increase rCBF in Brodmann’s area 19 (middle
occipital gyrus) (Mentis et al., 2001). Physostigmine has also
been reported to reduce visual responses in the calcarine sulcus
(corresponding to early visual cortex) but not in lateral occipital
cortex (Bentley et al., 2004).
Some of the heterogeneity in these results may be due to the
fact that response amplitude has often been confounded with
spatial spread in these studies. In addition, these studies gener-
ally modeled only positive responses to visual stimulation. In
the present study, both positive BOLD and negative BOLD re-
sponses to visual stimulation were observed in the same cortical
area. We employed retinotopic mapping to identify the bound-
aries of V1, V2, and V3 and used gray-matter segmentation and
flat mapping in order to visualize the spatial extent of the positive
and negative BOLD responses in each area. In addition, we did
not perform any statistical thresholding of fMRI responses, so
we were able to independently measure the effects of cholinergic
enhancement on spatial spread and on response amplitude.
These novel analysis methods showed that donepezil reduced
the number of positive BOLD pixels in early visual cortex as well
as the amplitude of excitatory visual responses in these pixels.
Local administration of ACh to visual cortex of anesthetized
animals has produced variable results. ACh has been reported
to increase visual responses (Sato et al., 1987; Sillito and
Kemp, 1983; Zinke et al., 2006), to increase (Zinke et al., 2006)
or have no effect on (Sato et al., 1987; Sillito and Kemp, 1983)
spontaneous activity, and to either decrease (Sato et al., 1987;
Zinke et al., 2006) or increase (Sillito and Kemp, 1983; Murphy
and Sillito, 1991) stimulus selectivity. It is difficult to relate our
findings to the single-unit electrophysiological results for at least
three reasons. First, the animal studies employed local adminis-
tration of cholinergic drugs, while we administered donepezil
systemically. Second, the electrophysiological studies typically
tailored the properties of the visual stimulus so that it was nearly
optimal for the recorded neuron. In contrast, our study involved
presentation of a single stimulus, and this stimulus was optimal
for only a small fraction of visual cortical neurons. Thus, the
fMRI responses we recorded represent a population average
of many neurons with a wide range of receptive field properties.
Finally, our experiments were performed in awake behaving hu-
mans, while the electrophysiological studies were conducted in
anesthetized animals. Many anesthetics strongly affect the activ-
ity of brain cholinergic systems (Backman et al., 2004), and the
interactions between the effects of anesthetic and those of local
administration of ACh are largely unknown.
Nonspecific Effects of Cholinergic Enhancement
Because the BOLD signal is a measure of blood oxygenation,
changes in this signal could in principle be due to any combina-
tion of changes in neural activity, neurovascular coupling, and di-
rect cholinergic effects on the vasculature. In fact, there is some
evidence for cholinergic modulation of brain vasculature. Electri-
cal stimulation of the nucleus basalis of Meynert, a cholinergic
basal forebrain nucleus, increased cerebral blood flow in rat cor-
tex, and this effect was blocked by systemic administration of
ACh receptor antagonists (Biesold et al., 1989). Also, intravenous
administration of nicotine has been reported to increase rCBF in
human occipital cortex, both during rest and during performance
of the perceptual maze test (Ghatan et al., 1998).
We performed a control experiment to assess the specificity of
donepezil’s effects on spatial spread and amplitude of visual re-
sponses. Donepezil had no effect on the amplitude of the breath
holding BOLD response and reduced the temporal delay of this
response in areas V1 and V3 (Figure 6). This decrease in temporal
delay is unlikely to have affected our spatial spread measure-
ments, as we defined the phase windows corresponding to pos-
itive and negative BOLD responses for each fMRI run based on
the two-Gaussian fit of the pixel phase histograms.
Origin of Negative BOLD Signals
Many studies have shown that visual responses in early visual
cortex consist of a positive BOLD response in the portions of
visual cortical areas that retinotopically represent the stimulus lo-
cations, surrounded by a negative BOLD response in adjacent
cortical regions (Bressler et al., 2007; Shmuel et al., 2002; Smith
et al., 2000; Tootell et al., 1998). One possible explanation of
negative BOLD responses is blood stealing, in which active cor-
tex diverts oxygenated blood away from adjacent locations,
resulting in a decrease in BOLD signal surrounding the stimulus
response. However, combined electrophysiological and fMRI
measurements in macaque early visual cortex have demon-
strated that negative BOLD responses to visual stimulation are
correlated with a decrease in neuronal firing rates in the same re-
gion (Shmuel et al., 2006). In addition, a visual stimulus restricted
to one visual hemifield can cause a positive BOLD response in
visual cortex contralateral to the stimulus and a negative BOLD
response in the ipsilateral hemisphere (Smith et al., 2004; Tootell910 Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc.
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based on blood stealing, as the positive and negative BOLD re-
gions represent adjacent visual field locations but are located in
different hemispheres. The two regions are neurally connected
by the corpus callosum, but they are served by largely indepen-
dent vasculature. Thus, the available evidence suggests that in
early visual cortex, negative BOLD responses in regions flanking
the visual stimulus representation are likely to reflect reductions
in neuronal firing rates.
In the present study, we observed a negative BOLD response
to visual stimulation in cortical regions a few centimeters away
from the positive BOLD response region (Figures 1 and 3 and
Figure S2). This negative BOLD often extended beyond the ec-
centricities used to retinotopically define V1, V2, and V3 (11,
far beyond the 4.5 radius of the checkerboard stimulus annulus
used to measure spatial spread). Surround suppression has
been quantified for single neurons in macaque V1 that had re-
ceptive fields with eccentricities similar to those in our stimulus
annulus (Ichida et al., 2007). In this study, some neurons ex-
hibited inhibitory surrounds that extended more than 13 of
visual angle away from the receptive field center. Surround sup-
pression in V1 has been attributed to feedback connections from
higher cortical areas, as single lateral connections in V1 are often
not long enough to directly connect the cortical locations repre-
senting the suppressing surround stimulus with those represent-
ing the center stimulus (Angelucci et al., 2002; Cavanaugh et al.,
2002). However, chains of lateral connections could potentially
also mediate long-range suppression. In the present study, the
relative contributions of lateral and feedback connections to
the negative BOLD response and to the spatial spread of the
positive BOLD response are unknown. Experiments in which
spatial attention is used to manipulate feedback signals to early
visual cortex will provide information regarding the effects of top-
down inputs on spatial integration in early visual cortex.
Conclusions
We have demonstrated that cholinergic enhancement with do-
nepezil reduces the spatial spread of excitatory visual responses
in early visual cortex. Retinotopic visual cortical areas provide an
excellent system for probing lateral spread of responses through
intracortical connections. Pharmacological manipulation of brain
cholinergic systems has been shown to affect performance on
a wide variety of perceptual and cognitive tasks, and many of
these effects can be accounted for by a model of cholinergic
regulation of the balance between afferent inputs and lateral
connections (Hasselmo and McGaughy, 2004). The specific con-
tributions of reduced visual cortical spatial integration by ACh to
visual perception are not yet known, but the available physiolog-
ical data result in clear predictions. If cholinergic enhancement
reduces the efficacy of lateral intracortical projections that
connect separate locations in retinotopic visual field maps in
early visual cortex, this should impair performance in tasks that
strongly depend on integration across visual space, such as per-
ceptual grouping or texture perception. On the other hand, tasks
that require segmentation of spatial locations in the visual field,
such as overcoming visual crowding or surround suppression,
may show an improvement in performance following cholinergic
enhancement.
Visual crowding results from excessive integration of stimuli
presented in the peripheral visual field (Levi, 2008). In healthy hu-
mans, crowding is easily overcome by eye movements that bring
the crowded stimuli into the central visual field. However, patients
with macular degeneration suffer from degeneration of the por-
tions of their retinae that represent the central visual field. Conse-
quently, their entire visual field is crowded, resulting in severe
impairments in reading, recognizing facial identity, and other
important visual functions. The present results suggest that the
cholinergic system may be a target for pharmacological treat-
ment of the perceptual consequences of macular degeneration.
EXPERIMENTAL PROCEDURES
Subjects
Five healthy subjects participated in the study, all of whom had extensive ex-
perience as subjects in psychophysical and fMRI experiments. Two subjects
were also authors of the study (subjects #1 and #4). All subjects provided writ-
ten informed consent, and the experimental protocol was approved by the
Committee for the Protection of Human Subjects at the University of California,
Berkeley. Each subject participated in one MR session to acquire high-resolu-
tion whole-brain anatomical images, at least one retinotopic mapping fMRI
session to define the boundaries of cortical areas V1, V2, and V3, and between
three and five pharmacology sessions to determine the effects of cholinergic
enhancement on visual responses in early visual cortex.
Pharmacology
Capsules containing either 5 mg donepezil (Aricept) or lactose placebo were
prepared by the Drug Products Services Laboratory at the University of Cali-
fornia, San Francisco. Donepezil is commonly used in the treatment of Alz-
heimer’s disease, and 5 mg represents the lowest dose prescribed to patients.
Subjects ingested either a donepezil or placebo capsule 3 hr before the begin-
ning of the fMRI scanning session. The timing of capsule administration is
based on the finding that peak plasma levels of donepezil are reached 4 hr
after oral administration at doses similar to the 5 mg dose used in our study
(Rogers and Friedhoff, 1998). All experiments were conducted in a double-
blind fashion. Pharmacology sessions were separated by at least 2 weeks
to allow donepezil to be completely eliminated (the half life of donepezil is
80 hr in humans [Rogers and Friedhoff, 1998]).
Visual Stimuli
Subject passively viewed an annulus containing a contrast-reversing checker-
board while maintaining fixation in the center of the annulus. The inner diame-
ter of the annulus was 3 of visual angle, and the outer diameter was 9. The
pixel intensities within the checkerboard were sinusoidally modulated in space
and time, with a spatial frequency of 2 cyc/ and a temporal frequency of
2.5 Hz. The stimulus contrast was 100%. Stimuli were presented on
a gamma-corrected flat-panel LCD monitor (MultiSync 2110, NEC, Itasca,
IL) that was electrically shielded to reduce fMRI artifacts due to radiofrequency
noise. The monitor was viewed with an angled mirror positioned above the
subject’s eyes, and the viewing distance was 185 cm. The checkerboard an-
nulus was presented for 9.6 s in block alternation with 9.6 s of a gray screen
with the same mean luminance as the checkerboard. Each fMRI run consisted
of 16 cycles of stimulus and gray screen, resulting in a total duration of 307.2 s
for each run. The total numbers of runs and sessions for each participant are
shown in Table 2. Subjects were instructed to continuously maintain fixation
throughout the stimulus and gray screen periods. The stimulus protocol was
written in MATLAB (The MathWorks, Inc., Natick, MA) using the Psychophys-
ics Toolbox (Brainard, 1997; Pelli, 1997).
fMRI Data Acquisition
fMRI experiments were conducted with a 4-Tesla Varian INOVA MR scanner
(Palo Alto, CA). A transmit/receive surface radiofrequency coil was used to
maximize contrast-to-noise ratio in occipital cortex. Functional echo-planar
images were acquired using a two-shot gradient-echo EPI sequence. The fieldNeuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc. 911
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64 3 64, resulting in an inplane voxel resolution of either 2.81 3 2.81 mm or
3.5 3 3.5 mm. The repetition time (TR) was 2.4 s, and the echo time (TE)
was 28 ms. Twenty slices in coronal orientation were prescribed with slice
thickness of 3 mm and a 0.3 mm interslice gap. A set of T1-weighted anatom-
ical images that were coplanar with the EPI images was acquired at the begin-
ning of every imaging session. In a separate session, a set of high-resolution
T1-weighted whole-brain anatomical images was acquired for each subject
to allow functional data to be combined across multiple scanning sessions.
fMRI Data Preprocessing
Each fMRI run began with a single blank period corresponding to one-half of
a stimulus cycle (4 TRs, or 9.6 s for passive viewing runs; 10 TRs, or 24 s for
breath holding runs). The data acquired during this blank period were not in-
cluded in the analysis. Head movements were corrected using a 3D image reg-
istration algorithm (MCFLIRT; Jenkinson et al., 2002). The time series at each
voxel were high-pass filtered to remove low-frequency noise (Smith et al.,
1999; Zarahn et al., 1997). Finally, each voxel’s time series was divided by
its mean intensity to convert the data from arbitrary units to percentage signal
modulation and to compensate for the decrease in mean image intensity as
a function of distance from the surface coil.
Definition of Early Visual Cortical Area Boundaries
The boundaries of cortical areas V1, V2, and V3 were defined using well-estab-
lished phase-encoded retinotopic mapping methods (DeYoe et al., 1996; En-
gel et al., 1994, 1997; Sereno et al., 1995). Stimuli were rotating checkerboard
wedges with check size scaled according to the cortical magnification factor in
human V1 (Slotnick et al., 2001). Although early visual cortical areas can be
mapped with these stimuli in the absence of explicit attentional demands,
we have found that many cortical areas contain topographic maps based on
both stimulus-driven and top-down spatial attention signals (Silver et al.,
2005). These sensory and attention maps are in correspondence in many vi-
sual cortical areas (Silver et al., 2005). To enhance signals in topographic areas
during retinotopic mapping, subjects performed a difficult target detection
task. The target could appear anywhere within the rotating wedge at unpre-
dictable times. This encouraged subjects to continuously maintain spatial at-
tention over the entire wedge. Subjects practiced the task in a behavioral test-
ing room to determine their performance as a function of eccentricity, and the
target sizes were scaled to insure that target detectability was equivalent at all
wedge locations. In the scanner, stimuli were presented using MR-compatible
goggles (Resonance Technology, Northridge, CA). The field of view used for
retinotopic mapping was approximately 22 3 30 of visual angle.
Partitioning of Visual Cortical Areas into Positive
and Negative BOLD Regions
For each subject, cortical gray matter voxels were segmented (Larsson, 2001).
Each fMRI run consisted of 16 cycles of block alternation of checkerboard
stimulus and blank screen. The cycle duration was 19.2 s, so the signal in
visually responsive voxels should modulate with a frequency of 1/19.2
s = 0.0521 Hz. A 0.0521 Hz sinusoid was fit to the fMRI time course of each
gray matter voxel in every run. The free parameters of the sinusoid fit were
its amplitude, corresponding to the magnitude of the visual response, and
its phase, corresponding to the delay in the fMRI response relative to the stim-
ulus cycle. These fitting parameters were then spatially transformed onto com-
putationally-flattened cortical patches.
For a given cortical area, the response phases exhibited a bimodal distribu-
tion, with one mode corresponding to a positive blood oxygenation level-de-
pendent (BOLD) response to the stimulus (activity higher for stimulus than
blank screen), and the other corresponding to a negative BOLD response (ac-
tivity higher for blank screen than stimulus). This bimodal distribution could
easily be observed in a histogram of the phase values for each pixel (Figure 1B
and Figure S1). The histogram was fit with two Gaussians, one for positive
BOLD and one for negative BOLD. The free parameters were the means,
standard deviations (widths), and amplitudes (heights) of the Gaussians and
a y-offset term that added a constant number of pixels to all response phases.
Optimization was performed using a sequential nonlinear method, imple-
mented as the function fminsearch in MATLAB. The fitting procedure was
carried out separately for both hemispheres in each visual area and each
fMRI run (consisting of sixteen stimulus cycles, or 307.2 s).
Hartigan’s dip test (Hartigan and Hartigan, 1985) for unimodality was applied
to the pixel histogram for each run, as implemented by Mechler and Ringach
(2002) (Matlab code available at http://web.mac.com/darioringach/lab/Data.
html). This tests the null hypothesis of a unimodal distribution and generates
a confidence measure that a given distribution is multimodal. 487 out of a total
of 504 histograms resulted in a Hartigan’s dip test p value of less than 0.05,
demonstrating that the signal-to-noise ratio for individual runs was sufficient
to be able to identify separate pixel populations with positive and negative
BOLD responses. fMRI runs that failed Hartigan’s dip test were excluded
from the analysis.
Breath Holding Task
Subjects performed block alternation of breath holding (24 s) and paced
breathing (24 s, eight expiration/inspiration cycles). Subjects were cued to be-
gin breath holding or to breathe in or out (for paced breathing) with text pre-
sented on the LCD monitor. Each fMRI run included seven cycles, for a total
of 336 s per run. A sinusoid with a period of 48 s was fit to the fMRI time series
for each voxel. The amplitude and phase of this sinusoid was computed for
each voxel and separately averaged for both hemispheres in each cortical
area. The total numbers of breath holding runs and sessions for each subject
are shown in Table 2.
Eye Tracking Experiments
Eye position was recorded outside of the scanner in a behavioral testing room
with an EyeLink 1000 system (SR Research, Osgoode, Ontario, Canada). A
calibration was performed before each run to allow measurement of eye po-
sition in units of degrees of visual angle. Horizontal and vertical eye position
were recorded at 1 kHz, and eye blinks were removed from the time series.
Four subjects participated in one placebo session and one donepezil session.
The experiments were conducted in a double-blind fashion, and the placebo
or donepezil capsule was administered 3 hr before the beginning of the
session, as in the fMRI experiments. Each subject participated in two 5 min
runs for each session. The stimulus annulus was identical to that used in the
fMRI experiment in size, spatial frequency, temporal frequency, and contrast.
The timing of the block alternation (stimulus versus gray screen) and number
of stimulus cycles were also equated in the fMRI and eye tracking experi-
ments.
SUPPLEMENTAL DATA
The Supplemental Data include eight figures and can be found with this article
online at http://www.neuron.org/supplemental/S0896-6273(08)00841-6.
Table 2. Number of fMRI Sessions and Runs Completed by Each
Participant
Placebo Donepezil
Subject
#
#
Sessions
PV
Runs
BH
Runs
#
Sessions
PV
Runs
BH
Runs
1 3 10 4 2 8 4
2 2 7 4 3 12 4
3 1 4 2 2 8 3
4 3 12 5 2 7 4
5 2 8 4 2 8 4
A single PV run represents5 min of passive viewing of the checkerboard
annulus alternating with a blank screen. A single BH run represents
6 min of alternation of breath holding with paced breathing.912 Neuron 60, 904–914, December 11, 2008 ª2008 Elsevier Inc.
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